Alexis Hammond

Assistant Professor

20042018
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Alexis Hammond is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Patient Navigation Medicine & Life Sciences
Viral Load Medicine & Life Sciences
Modulators Chemical Compounds
Metabotropic Glutamate 5 Receptor Medicine & Life Sciences
Motivation Medicine & Life Sciences
Allosteric Site Medicine & Life Sciences
Fear Medicine & Life Sciences
HIV Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

Enhancing Patient Navigation with Contingent Incentives to Improve Healthcare Behaviors and Viral Load Suppression of Persons with HIV and Substance Use

Stitzer, M. L., Hammond, A., Matheson, T., Sorensen, J. L., Feaster, D. J., Duan, R., Gooden, L., Del Rio, C. & Metsch, L. R., Jul 1 2018, In : AIDS Patient Care and STDs. 32, 7, p. 288-296 9 p.

Research output: Contribution to journalArticle

Patient Navigation
Viral Load
Motivation
HIV
Delivery of Health Care

Perceived attitudes about substance use in anonymous social media posts near college campuses: Observational study

Hammond, A., Paul, M. J., Hobelmann, J., Koratana, A. R., Dredze, M. & Chisolm, M. S., Aug 1 2018, In : Journal of Medical Internet Research. 20, 8, e52.

Research output: Contribution to journalArticle

Social Media
Observational Studies
Alcohols
Mobile Applications
Posters

Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study

Stitzer, M. L., Matheson, T., Cunningham, C., Sorensen, J. L., Feaster, D. J., Gooden, L., Hammond, A., Fitzsimons, H. & Metsch, L. R., Jun 27 2017, In : Addiction science & clinical practice. 12, 1, 1 p.

Research output: Contribution to journalArticle

Patient Navigation
Viral Load
Motivation
HIV
Appointments and Schedules

N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement

Gregory, K. J., Herman, E. J., Ramsey, A. J., Hammond, A., Byun, N. E., Stauffer, S. R., Manka, J. T., Jadhav, S., Bridges, T. M., Weaver, C. D., Niswender, C. M., Steckler, T., Drinkenburg, W. H., Ahnaou, A., Lavreysen, H., Macdonald, G. J., Bartolomé, J. M., Mackie, C., Hrupka, B. J., Caron, M. G. & 4 others, Daigle, T. L., Lindsley, C. W., Conn, P. J. & Jones, C. K., Nov 2013, In : Journal of Pharmacology and Experimental Therapeutics. 347, 2, p. 438-457 20 p.

Research output: Contribution to journalArticle

Metabotropic Glutamate 5 Receptor
N-Methylaspartate
Schizophrenia
Startle Reflex
Allosteric Site

Discovery of a novel chemical class of mGlu5 allosteric ligands with distinct modes of pharmacology

Hammond, A., Rodriguez, A. L., Townsend, S. D., Niswender, C. M., Gregory, K. J., Lindsley, C. W. & Conn, P. J., Oct 20 2010, In : ACS Chemical Neuroscience. 1, 10, p. 702-716 15 p.

Research output: Contribution to journalArticle

Allosteric Site
Modulators
Pharmacology
Ligands
Chemical activation